Topical application of antifibrinolytic drugs for on-pump cardiac surgery: A systematic review and meta-analysis

Canadian Journal of Anesthesia

Volumn 56, Issue 3, 2009, Pages 202-212

  Abrishami, Amir ^a   Chung, Frances ^a   Wong, Jean ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ; PLACEBO; TRANEXAMIC ACID;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; HEART SURGERY; HUMAN; INCIDENCE; MEDICAL LITERATURE; MEDICAL RESEARCH; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUBE;

ADMINISTRATION, TOPICAL; AGED; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY BYPASS; FEMALE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 61449083511     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12630-008-9038-x     Document Type: Article

References (38)

1. D Paparella SJ Brister MR Buchanan 2004 Coagulation disorders of cardiopulmonary bypass: a review Intensive Care Med 30 1873 1881
2. M Hartmann C Sucker O Boehm A Koch S Loer K Zacharowski 2006 Effects of cardiac surgery on hemostasis Transfus Med Rev 20 230 241
3. B Hutton D Fergusson A Tinmouth L McIntyre A Kmetic PC Hebert 2005 Transfusion rates vary significantly amongst Canadian medical centres Can J Anesth 52 581 590
4. K Karkouti DN Wijeysundera TM Yau 2004 The independent association of massive blood loss with mortality in cardiac surgery Transfusion 44 1453 1462
5. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007; (4): CD001886.
6. DT Mangano Y Miao A Vuylsteke 2007 Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery JAMA 297 471 479
7. K Karkouti WS Beattie KM Dattilo 2006 A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery Transfusion 46 327 338
8. JR Brown NJ Birkmeyer GT O'Connor 2007 Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery Circulation 115 2801 2813
9. W Beierlein AM Scheule W Dietrich G Ziemer 2005 Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions Ann Thorac Surg 79 741 748
10. S Westaby T Katsumata 1998 Aprotinin and vein graft occlusion-the controversy continues J Thorac Cardiovasc Surg 116 731 733
11. DA Fergusson PC Hebert CD Mazer 2008 A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2319 2331
12. J Cid M Lozano 2005 Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials Transfusion 45 1302 1307
13. SH Baek JA Hrabie LK Keefer 2002 Augmentation of Intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty Circulation 105 2779 2784
14. TM Kolettis N Kazakos CS Katsouras 2005 Intrapericardial drug delivery: pharmacologic properties and long-term safety in swine Int J Cardiol 99 415 421
15. S Waxman TC Pulerwitz KA Rowe WC Quist RL Verrier 2000 Preclinical safety testing of percutaneous transatrial access to the normal pericardial space for local cardiac drug delivery and diagnostic sampling Catheter Cardiovasc Interv 49 472 477
16. A Abul-Azm KM Abdullah 2006 Effect of topical tranexamic acid in open heart surgery Eur J Anaesthesiol 23 380 384
17. M De Bonis F Cavaliere F Alessandrini 2000 Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study J Thorac Cardiovasc Surg 119 575 580
18. F Isgro O Stanisch AH Kiessling S Gurler P Hellstern W Saggau 2002 Topical application of aprotinin in cardiac surgery Perfusion 17 347 351
19. PN Khalil M Siebeck M Ismail 2006 The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery Eur J Med Res 11 386 393
20. DJ O'Regan N Giannopoulos N Mediratta 1994 Topical aprotinin in cardiac operations Ann Thorac Surg 58 778 781
21. H Tatar S Cicek U Demirkilic 1993 Topical use of aprotinin in open heart operations Ann Thorac Surg 55 659 661
22. Schulz KF, Chalmers I, Altman DG, Grimes DA, Dore CJ. The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. Online J Curr Clin Trials 1995; Doc No 197: (81 paragraphs).
23. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 (updated May 2005). 4.2.5 ed. Chichester: Wiley; 2005.
24. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 629 634
25. CB Begg M Mazumdar 1994 Operating characteristics of a rank correlation test for publication bias Biometrics 50 1088 1101
26. J Mand'ak V Lonsky J Dominik 1999 Topical use of aprotinin in coronary artery bypass surgery Acta Medica (Hradec Kralove) 42 4 139 44
27. O Stanisch F Isgro 2002 Topical application of aprotinin in cardiac surgery (German) Z Herz- Thorax- Gefäßchir 16 25 30
28. F Bizzarri E Carone G Capannini 1998 Bleeding reduction in cardiac surgery: a combined approach J Thorac Cardiovasc Surg 115 1227
29. A Yasim R Asik E Atahan 2005 Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery (Turkish) Anadolu Kardiyol Derg 5 36 40
30. D Baric B Biocina D Unic 2007 Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study Eur J Cardiothorac Surg 31 366 371
31. PN Khalil M Ismail P Kalmar KG von G Marx 2004 Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass Thromb Haemost 92 3 568 574
32. N Tabuchi J de Haan PW Boonstra W van Oeveren 1993 Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass J Thorac Cardiovasc Surg 106 828 833
33. UU Nkere SA Whawell EM Thompson JN Thompson KM Taylor 1993 Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass J Thorac Cardiovasc Surg 106 339 345
34. M Jares T Vanek F Bednar M Maly J Snircova Z Straka 2007 Off-pump versus on-pump coronary artery surgery Int Heart J 48 57 67
35. T Tzonos D Giromini 1981 Aprotinin for intraoperative haemostasis Neurosurg Rev 4 193 194
36. EL Labadie D Glover 1975 Local alterations of hemostatic-fibrinolytic mechanisms in reforming subdural hematomas Neurology 25 669 675
37. LL Kjaergard J Villumsen C Gluud 2001 Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses Ann Intern Med 135 982 989
38. RD Slight NJ Bappu OC Nzewi DB McClelland PS Mankad 2006 Perioperative red cell, plasma, and blood volume change in patients undergoing cardiac surgery Transfusion 46 392 397